Concourse Financial Group Securities’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 48 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 2272 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 2270 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 2325 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 2332 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 2300 |
|
|
2023
Q3 | – | Sell |
-100
| Closed | -$2.4K | – | 2328 |
|
|
2023
Q2 | $2.4K | Hold |
100
| – | – | ﹤0.01% | 1982 |
|
|
2023
Q1 | $1.88K | Hold |
100
| – | – | ﹤0.01% | 2066 |
|
|
2022
Q4 | $1.59K | Buy |
+100
| New | +$1.59K | ﹤0.01% | 2076 |
|
|
2022
Q3 | – | Sell |
-100
| Closed | -$1K | – | 2002 |
|
|
2022
Q2 | $1K | Hold |
100
| – | – | ﹤0.01% | 2072 |
|
|
2022
Q1 | $2K | Hold |
100
| – | – | ﹤0.01% | 1986 |
|
|
2021
Q4 | $2K | Hold |
100
| – | – | ﹤0.01% | 2169 |
|
|
2021
Q3 | $2K | Hold |
100
| – | – | ﹤0.01% | 2197 |
|
|
2021
Q2 | $2K | Sell |
100
-100
| -50% | -$2K | ﹤0.01% | 2157 |
|
|
2021
Q1 | $5K | Sell |
200
-100
| -33% | -$2.5K | ﹤0.01% | 1945 |
|
|
2020
Q4 | $16K | Buy |
+300
| New | +$16K | ﹤0.01% | 1527 |
|
|
2020
Q3 | – | Sell |
-495
| Closed | -$24K | – | 2162 |
|
|
2020
Q2 | $24K | Sell |
495
-220
| -31% | -$10.7K | ﹤0.01% | 1225 |
|
|
2020
Q1 | $30K | Buy |
+715
| New | +$30K | ﹤0.01% | 1086 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 2055 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 1749 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 2210 |
|
|
2019
Q1 | – | Sell |
-128
| Closed | -$2K | – | 2258 |
|
|
2018
Q4 | $2K | Buy |
128
+11
| +9% | +$172 | ﹤0.01% | 1877 |
|
|
2018
Q3 | $2K | Buy |
+117
| New | +$2K | ﹤0.01% | 1551 |
|